HYPONATREMIA AND FLUID RETENTION IN A NEONATE ASSOCIATED WITH MATERNAL NAPROXEN OVERDOSAGE

被引：13

作者：

ALUNJONES, E

WILLIAMS, J

机构：

来源：

JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1986年 / 24卷 / 03期

关键词：

D O I：

10.3109/15563658608990463

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：257 / 260

页数：4

共 9 条

[1]

FELDMAN D, 1978, AM J PHYSIOL, V234, P490

[2]

FREDELL EW, 1977, JAMA-J AM MED ASSOC, V238, P938

[3]

HALLIDAY HL, 1979, PEDIATRICS, V64, P154

[4] PHARMACOKINETICS AND METABOLISM OF NAPROXEN IN CHILDREN [J].

KAUFFMANN, RE ;

BOLLIGER, RO ;

WAN, SH ;

OREN, J .

DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1982, 5 (3-4) :143-150

[5] NAPROXEN METABOLISM IN MAN [J].

SEGRE, EJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (04) :316-323

[6] SALICYLATE POISONING COMPLICATED BY FLUID RETENTION [J].

TEMPLE, AR ;

GEORGE, DJ ;

DONE, AK ;

THOMPSON, JA .

CLINICAL TOXICOLOGY, 1976, 9 (01) :61-68

[7] INHIBITION OF PROSTAGLANDIN SYNTHESIS AS A MECHANISM OF ACTION FOR ASPIRIN-LIKE DRUGS [J].

VANE, JR .

NATURE-NEW BIOLOGY, 1971, 231 (25) :232-&

[8]

WILKINSON AR, 1980, LANCET, V2, P591

[9] PERSISTENT PULMONARY-HYPERTENSION AND ABNORMAL PROSTAGLANDIN-E LEVELS IN PRETERM INFANTS AFTER MATERNAL TREATMENT WITH NAPROXEN [J].

WILKINSON, AR ;

AYNSLEYGREEN, A ;

MITCHELL, MD .

ARCHIVES OF DISEASE IN CHILDHOOD, 1979, 54 (12) :942-945

← 1 →